ID   ADOK_MYCTA              Reviewed;         324 AA.
AC   A5U4N0;
DT   02-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   10-JUL-2007, sequence version 1.
DT   10-FEB-2021, entry version 75.
DE   RecName: Full=Adenosine kinase {ECO:0000303|PubMed:14594827};
DE            Short=ADK {ECO:0000250|UniProtKB:P9WID5};
DE            Short=AK {ECO:0000303|PubMed:14594827};
DE            EC=2.7.1.20 {ECO:0000269|PubMed:14594827};
GN   Name=adoK {ECO:0000303|PubMed:14594827}; Synonyms=cbhK;
GN   OrderedLocusNames=MRA_2218;
OS   Mycobacterium tuberculosis (strain ATCC 25177 / H37Ra).
OC   Bacteria; Actinobacteria; Corynebacteriales; Mycobacteriaceae;
OC   Mycobacterium; Mycobacterium tuberculosis complex.
OX   NCBI_TaxID=419947;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 25177 / H37Ra;
RX   PubMed=18584054; DOI=10.1371/journal.pone.0002375;
RA   Zheng H., Lu L., Wang B., Pu S., Zhang X., Zhu G., Shi W., Zhang L.,
RA   Wang H., Wang S., Zhao G., Zhang Y.;
RT   "Genetic basis of virulence attenuation revealed by comparative genomic
RT   analysis of Mycobacterium tuberculosis strain H37Ra versus H37Rv.";
RL   PLoS ONE 3:E2375-E2375(2008).
RN   [2]
RP   PROTEIN SEQUENCE OF 2-16, FUNCTION, CATALYTIC ACTIVITY, COFACTOR,
RP   BIOPHYSICOCHEMICAL PROPERTIES, SUBSTRATE SPECIFICITY, SUBUNIT, ACTIVITY
RP   REGULATION, AND PATHWAY.
RC   STRAIN=ATCC 25177 / H37Ra;
RX   PubMed=14594827; DOI=10.1128/jb.185.22.6548-6555.2003;
RA   Long M.C., Escuyer V., Parker W.B.;
RT   "Identification and characterization of a unique adenosine kinase from
RT   Mycobacterium tuberculosis.";
RL   J. Bacteriol. 185:6548-6555(2003).
CC   -!- FUNCTION: Catalyzes the phosphorylation of adenosine to adenosine
CC       monophosphate (AMP). Can also catalyze the phosphorylation of the
CC       adenosine analog 2-methyladenosine (methyl-Ado) to methyl-AMP, the
CC       first step in the metabolism of this compound to an active form that
CC       displays antitubercular activity. Is not active on guanosine, inosine,
CC       deoxyadenosine, cytidine, uridine, or thymidine. Prefers dGTP and GTP
CC       to ATP as phosphate donors in vitro. {ECO:0000269|PubMed:14594827}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=adenosine + ATP = ADP + AMP + H(+); Xref=Rhea:RHEA:20824,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16335, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:456215, ChEBI:CHEBI:456216; EC=2.7.1.20;
CC         Evidence={ECO:0000269|PubMed:14594827};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=adenosine + GTP = AMP + GDP + H(+); Xref=Rhea:RHEA:52532,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16335, ChEBI:CHEBI:37565,
CC         ChEBI:CHEBI:58189, ChEBI:CHEBI:456215;
CC         Evidence={ECO:0000269|PubMed:14594827};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=adenosine + dGTP = AMP + dGDP + H(+); Xref=Rhea:RHEA:52536,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16335, ChEBI:CHEBI:58595,
CC         ChEBI:CHEBI:61429, ChEBI:CHEBI:456215;
CC         Evidence={ECO:0000269|PubMed:14594827};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:14594827};
CC   -!- ACTIVITY REGULATION: The enzyme is subject to substrate inhibition by
CC       adenosine and is competitively inhibited by the adenosine analog
CC       iodotubercidin. Unlike other adenosine kinases it is not stimulated by
CC       inorganic phosphate. Activity is stimulated in the presence of
CC       potassium, resulting in a 13- and 300-fold increase in the catalytic
CC       efficiency with adenosine and methyl-Ado as substrate, respectively;
CC       the stimulatory effects are not observed in the presence of NaCl or
CC       LiCl. {ECO:0000269|PubMed:14594827}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.80 uM for adenosine (in the presence of 10 mM KCl)
CC         {ECO:0000269|PubMed:14594827};
CC         KM=3.4 uM for adenosine (in the absence of KCl)
CC         {ECO:0000269|PubMed:14594827};
CC         KM=79 uM for methyl-adenosine (in the presence of 10 mM KCl)
CC         {ECO:0000269|PubMed:14594827};
CC         KM=709 uM for methyl-adenosine (in the absence of KCl)
CC         {ECO:0000269|PubMed:14594827};
CC         KM=1100 uM for ATP (in the presence of 10 mM KCl)
CC         {ECO:0000269|PubMed:14594827};
CC         Vmax=180 nmol/min/mg enzyme with adenosine as substrate (in the
CC         presence of 10 mM KCl) {ECO:0000269|PubMed:14594827};
CC         Vmax=60 nmol/min/mg enzyme with adenosine as substrate (in the
CC         absence of KCl) {ECO:0000269|PubMed:14594827};
CC         Vmax=72 nmol/min/mg enzyme with methyl-adenosine as substrate (in the
CC         presence of 10 mM KCl) {ECO:0000269|PubMed:14594827};
CC         Vmax=2.3 nmol/min/mg enzyme with methyl-adenosine as substrate (in
CC         the absence of KCl) {ECO:0000269|PubMed:14594827};
CC         Note=GTP and dGTP are the best phosphate donors, with 2.5 and 4.7
CC         times the activity observed with ATP, respectively. UTP, dATP, and
CC         dTTP exhibit about 33% of the activity observed with ATP, while CTP
CC         and dCTP are the worst phosphate donors, with 1.7 and 0.2% of the
CC         activity observed with ATP, respectively. Since K(+) exists at
CC         millimolar levels within cells, stimulation by K(+) is
CC         physiologically relevant, and kinetic values obtained in the presence
CC         of K(+) more closely reflect the true physiological state of the
CC         enzyme than values obtained in the absence of K(+).
CC         {ECO:0000269|PubMed:14594827};
CC       pH dependence:
CC         Optimum pH is 8-11. Activity decreases rapidly at values above pH 11
CC         and below pH 8. Is inactive at pH 4.3. {ECO:0000269|PubMed:14594827};
CC   -!- PATHWAY: Purine metabolism; AMP biosynthesis via salvage pathway; AMP
CC       from adenosine: step 1/1. {ECO:0000305|PubMed:14594827}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:14594827}.
CC   -!- SIMILARITY: Belongs to the carbohydrate kinase PfkB family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP000611; ABQ73980.1; -; Genomic_DNA.
DR   RefSeq; WP_003411414.1; NZ_CP016972.1.
DR   SMR; A5U4N0; -.
DR   STRING; 419947.MRA_2218; -.
DR   EnsemblBacteria; ABQ73980; ABQ73980; MRA_2218.
DR   GeneID; 45426178; -.
DR   KEGG; mra:MRA_2218; -.
DR   eggNOG; COG0524; Bacteria.
DR   HOGENOM; CLU_027634_5_2_11; -.
DR   OMA; AAQVGCM; -.
DR   OrthoDB; 1604782at2; -.
DR   SABIO-RK; A5U4N0; -.
DR   UniPathway; UPA00588; UER00659.
DR   Proteomes; UP000001988; Chromosome.
DR   GO; GO:0004001; F:adenosine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0044209; P:AMP salvage; IEA:UniProtKB-UniPathway.
DR   GO; GO:0006166; P:purine ribonucleoside salvage; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.1190.20; -; 1.
DR   InterPro; IPR002173; Carboh/pur_kinase_PfkB_CS.
DR   InterPro; IPR011611; PfkB_dom.
DR   InterPro; IPR029056; Ribokinase-like.
DR   Pfam; PF00294; PfkB; 1.
DR   SUPFAM; SSF53613; SSF53613; 1.
DR   PROSITE; PS00583; PFKB_KINASES_1; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Direct protein sequencing; Kinase; Magnesium;
KW   Nucleotide-binding; Purine salvage; Transferase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:14594827"
FT   CHAIN           2..324
FT                   /note="Adenosine kinase"
FT                   /id="PRO_0000306417"
FT   NP_BIND         223..228
FT                   /note="ATP"
FT                   /evidence="ECO:0000250|UniProtKB:P9WID5"
FT   REGION          172..173
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000250|UniProtKB:P9WID5"
FT   ACT_SITE        257
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P9WID5"
FT   BINDING         8
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P9WID5"
FT   BINDING         12
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P9WID5"
FT   BINDING         36
FT                   /note="Substrate; shared with dimeric partner"
FT                   /evidence="ECO:0000250|UniProtKB:P9WID5"
FT   BINDING         48
FT                   /note="Substrate; via amide nitrogen"
FT                   /evidence="ECO:0000250|UniProtKB:P9WID5"
FT   BINDING         52
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P9WID5"
FT   BINDING         102
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P9WID5"
FT   BINDING         116
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P9WID5"
FT   BINDING         195
FT                   /note="ATP"
FT                   /evidence="ECO:0000250|UniProtKB:P9WID5"
FT   BINDING         256
FT                   /note="ATP; via amide nitrogen"
FT                   /evidence="ECO:0000250|UniProtKB:P9WID5"
FT   BINDING         257
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P9WID5"
SQ   SEQUENCE   324 AA;  34472 MW;  0C072206A3210A1D CRC64;
     MTIAVTGSIA TDHLMRFPGR FSEQLLPEHL HKVSLSFLVD DLVMHRGGVA GNMAFAIGVL
     GGEVALVGAA GADFADYRDW LKARGVNCDH VLISETAHTA RFTCTTDVDM AQIASFYPGA
     MSEARNIKLA DVVSAIGKPE LVIIGANDPE AMFLHTEECR KLGLAFAADP SQQLARLSGE
     EIRRLVNGAA YLFTNDYEWD LLLSKTGWSE ADVMAQIDLR VTTLGPKGVD LVEPDGTTIH
     VGVVPETSQT DPTGVGDAFR AGFLTGRSAG LGLERSAQLG SLVAVLVLES TGTQEWQWDY
     EAAASRLAGA YGEHAAAEIV AVLA
//
